Can SAGA Metals Corp. turn a Rio Tinto castoff into Quebec’s next titanium discovery story? (TSXV: SAGA)
What Olaplex Holdings, Inc.’s $2.06-per-share buyout by Henkel AG & Co. KGaA signals for beauty sector consolidation (NASDAQ: OLPX)
What Cadre Holdings, Inc.’s $10.3m acquisition signals about consolidation in tactical gear markets (NYSE: CDRE)
Rhinebeck Bank taps MANTL for omnichannel account opening as Alkami Technology (ALKT) accelerates post-acquisition integration
Read More 5 minute read Pharma Industry News Novo Nordisk’s Alzheimer’s treatment hopes crash as semaglutide fails to slow cognitive decline Novo Nordisk’s GLP-1 pill failed in Alzheimer’s trials, raising questions on neurology diversification. Read what this means for its pipeline and stock. byPallavi MadhirajuNovember 24, 2025